NCT04044937 2026-03-11
UC-GlioFET
University of California, San Francisco
Phase 2 Completed
Clinical Trials
24 trialsNCT02020720 2025-01-23
18F-DOPA-PET in Planning Surgery in Patients With Gliomas
Mayo Clinic
Phase EARLY_PHASE1 Completed
NCT04752267 2024-05-24
18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain Metastases
University of Southern California
Phase EARLY_PHASE1 Completed
NCT05054998 2024-05-01
Dual Time Point FDG PET/MRI Scan in Improving the Imaging Cancer Patients With Brain Metastases
M.D. Anderson Cancer Center
Phase 4 Completed
NCT06257498 2024-02-14
Heads-Up
Nottingham University Hospitals NHS Trust
Phase NA Completed
NCT02073968 2024-01-25
PAINT
Albert Einstein College of Medicine
Phase 2 Completed
NCT03680144 2024-01-11
Utility of Perfusion MRI to Detect Radiation Necrosis in Patients With Brain Metastases
Emory University
Phase NA Completed
NCT04132843 2022-11-21
Novel MRI Techniques for the Characterization and Treatment Assessment of High Grade Brain Lesions
M.D. Anderson Cancer Center
Phase NA Completed
NCT02843230 2022-04-08
Monitoring Anti-angiogenic Therapy in Brain Tumors by Advanced MRI
Massachusetts General Hospital
Completed
NCT00597246 2020-12-17
Imaging Brain Tumors With FACBC and Methionine
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT01674582 2020-09-03
Treatment Effects Inclusive Cognitive Impact and Possibilities to Individually Adjusted Treatment in Patients With Intracranial Tumors With Clinical, Neuropsychological and Imaging Parameters
Lund University Hospital
Phase NA Completed
NCT01228448 2020-08-18
In-Room PET in Proton Radiation Therapy
Massachusetts General Hospital
Phase NA Completed
NCT02167204 2020-01-13
18F-FLT PET/CT in Measuring Cell Proliferation in Patients With Brain Tumors
University of Washington
Phase NA Completed
NCT01516905 2019-11-15
PET/CT Imaging of Malignant Brain Tumors With 124I-NM404
University of Wisconsin, Madison
Completed
NCT02120287 2019-05-07
Border Zone Stereotactic Radiosurgery With Bevacizumab in Patients With Glioblastoma Multiforme
University of Pittsburgh
Phase 2 Completed
NCT00276770 2019-02-27
Positron Emission Tomography Using Fluorothymidine F 18 in Finding Recurrent Disease in Patients With Gliomas
University of Washington
Phase NA Completed
NCT00207298 2019-01-10
18F-fluorodeoxyglucose (18F-FDG) Positron Emission Tomography in Oncology
British Columbia Cancer Agency
Completed
NCT01342757 2018-01-29
Magnetic Resonance Spectroscopy Imaging in Predicting Response to Vorinostat and Temozolomide in Patients With Recurrent or Progressive Glioblastoma
National Cancer Institute (NCI)
Phase NA Completed
NCT02452216 2017-08-31
Using Ferumoxytol-Enhanced MRI to Measure Inflammation in Patients With Brain Tumors or Other Conditions of the CNS
Stanford University
Phase EARLY_PHASE1 Completed
NCT00123760 2016-02-25
Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer
AHS Cancer Control Alberta
Phase 2/3 Completed
NCT00492089 2014-05-09
Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT01018329 2012-12-11
Magnetic Resonance Imaging in Evaluating Response to RadiationTherapy in Patients With High Grade Glioma
Abramson Cancer Center at Penn Medicine
Phase NA Completed
NCT00897611 2012-11-30
Tumor DNA and MRI/CT Scan Findings in Patients With Grade III or Grade IV Malignant Glioma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase NA Completed
NCT00777686 2012-03-30
Measuring Non-Enhancing Glioblastoma Progression
M.D. Anderson Cancer Center
Completed